1-12192870-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001066.3(TNFRSF1B):​c.559G>A​(p.Val187Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0017 in 1,613,408 control chromosomes in the GnomAD database, including 38 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0086 ( 20 hom., cov: 33)
Exomes 𝑓: 0.00098 ( 18 hom. )

Consequence

TNFRSF1B
NM_001066.3 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.801

Publications

8 publications found
Variant links:
Genes affected
TNFRSF1B (HGNC:11917): (TNF receptor superfamily member 1B) The protein encoded by this gene is a member of the TNF-receptor superfamily. This protein and TNF-receptor 1 form a heterocomplex that mediates the recruitment of two anti-apoptotic proteins, c-IAP1 and c-IAP2, which possess E3 ubiquitin ligase activity. The function of IAPs in TNF-receptor signalling is unknown, however, c-IAP1 is thought to potentiate TNF-induced apoptosis by the ubiquitination and degradation of TNF-receptor-associated factor 2, which mediates anti-apoptotic signals. Knockout studies in mice also suggest a role of this protein in protecting neurons from apoptosis by stimulating antioxidative pathways. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0032384992).
BP6
Variant 1-12192870-G-A is Benign according to our data. Variant chr1-12192870-G-A is described in ClinVar as [Benign]. Clinvar id is 734527.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00862 (1313/152250) while in subpopulation AFR AF = 0.0302 (1255/41522). AF 95% confidence interval is 0.0288. There are 20 homozygotes in GnomAd4. There are 607 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 20 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TNFRSF1BNM_001066.3 linkc.559G>A p.Val187Met missense_variant Exon 6 of 10 ENST00000376259.7 NP_001057.1 P20333-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TNFRSF1BENST00000376259.7 linkc.559G>A p.Val187Met missense_variant Exon 6 of 10 1 NM_001066.3 ENSP00000365435.3 P20333-1
TNFRSF1BENST00000492361.1 linkn.548G>A non_coding_transcript_exon_variant Exon 5 of 9 1
TNFRSF1BENST00000489921.1 linkn.271G>A non_coding_transcript_exon_variant Exon 3 of 3 3

Frequencies

GnomAD3 genomes
AF:
0.00860
AC:
1309
AN:
152132
Hom.:
20
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0302
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00281
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000882
Gnomad OTH
AF:
0.00382
GnomAD2 exomes
AF:
0.00224
AC:
557
AN:
249072
AF XY:
0.00169
show subpopulations
Gnomad AFR exome
AF:
0.0286
Gnomad AMR exome
AF:
0.00191
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000196
Gnomad OTH exome
AF:
0.000328
GnomAD4 exome
AF:
0.000979
AC:
1431
AN:
1461158
Hom.:
18
Cov.:
32
AF XY:
0.000850
AC XY:
618
AN XY:
726796
show subpopulations
African (AFR)
AF:
0.0324
AC:
1084
AN:
33468
American (AMR)
AF:
0.00230
AC:
103
AN:
44688
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26090
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39680
South Asian (SAS)
AF:
0.000186
AC:
16
AN:
86194
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53278
Middle Eastern (MID)
AF:
0.00121
AC:
7
AN:
5766
European-Non Finnish (NFE)
AF:
0.0000882
AC:
98
AN:
1111630
Other (OTH)
AF:
0.00204
AC:
123
AN:
60364
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
81
161
242
322
403
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00862
AC:
1313
AN:
152250
Hom.:
20
Cov.:
33
AF XY:
0.00816
AC XY:
607
AN XY:
74426
show subpopulations
African (AFR)
AF:
0.0302
AC:
1255
AN:
41522
American (AMR)
AF:
0.00281
AC:
43
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10608
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.0000882
AC:
6
AN:
68014
Other (OTH)
AF:
0.00378
AC:
8
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
67
134
201
268
335
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00325
Hom.:
10
Bravo
AF:
0.00978
ESP6500AA
AF:
0.0256
AC:
113
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.00267
AC:
324
Asia WGS
AF:
0.00115
AC:
4
AN:
3478
EpiCase
AF:
0.000164
EpiControl
AF:
0.000356

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.65
T
BayesDel_noAF
Benign
-0.68
CADD
Benign
1.2
DANN
Benign
0.91
DEOGEN2
Benign
0.17
T
Eigen
Benign
-1.4
Eigen_PC
Benign
-1.5
FATHMM_MKL
Benign
0.027
N
LIST_S2
Benign
0.81
T
MetaRNN
Benign
0.0032
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.85
L
PhyloP100
-0.80
PrimateAI
Benign
0.25
T
PROVEAN
Benign
-0.29
N
REVEL
Benign
0.18
Sift
Benign
0.069
T
Sift4G
Benign
0.095
T
Polyphen
0.096
B
Vest4
0.084
MVP
0.51
MPC
0.34
ClinPred
0.0020
T
GERP RS
-4.5
Varity_R
0.10
gMVP
0.21
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2228494; hg19: chr1-12252927; COSMIC: COSV99058945; COSMIC: COSV99058945; API